Does predialysis nephrology care influence patient survival after initiation of dialysis?
暂无分享,去创建一个
A. Collins | D. Gilbertson | J. Xue | B. Pereira | W. Kazmi | G. Obrador | Allan J Collins | David T Gilbertson | Samina S Khan | Jay L Xue | Waqar H Kazmi | Gregorio T Obrador | Brian J G Pereira | Samina S. Khan
[1] H. Jacobson,et al. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. , 1995, Nihon Jinzo Gakkai shi.
[2] F. Port,et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] S. Klahr. The modification of diet in renal disease study. , 1989, The New England journal of medicine.
[4] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] A. Collins,et al. Hematocrit level and associated mortality in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.
[6] J. Avorn,et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. , 2002, Journal of clinical epidemiology.
[7] W. Owen. Status of hemodialysis adequacy in the United States: does it account for improved patient survival? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] M. Saul,et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. , 2000, The American journal of medicine.
[9] Giuseppe Remuzzi,et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria , 1999, The Lancet.
[10] W. van Biesen,et al. The pattern of referral of patients with end-stage renal disease to the nephrologist--a European survey. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] P. Roderick,et al. Late referral for dialysis: improving the management of chronic renal disease. , 2002, QJM : monthly journal of the Association of Physicians.
[12] W. Keane,et al. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] Nancy Fink,et al. The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.
[14] R. Brant,et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. , 2001, JAMA.
[15] B. Kasiske. Hyperlipidemia in patients with chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] A. Kausz,et al. Hospital utilization among chronic dialysis patients. , 2000, Journal of the American Society of Nephrology : JASN.
[17] R. Sesso,et al. Late diagnosis of chronic renal failure and mortality on maintenance dialysis , 1996 .
[18] T. Greene,et al. Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.
[19] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[20] G. Shearer,et al. Mechanisms of hypoalbuminemia in hemodialysis patients (Kidney International 48: (510-516)) , 1995 .
[21] A. Levin,et al. Elevated levels of serum creatinine: recommendations for management and referral. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[22] Z. Massy,et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] R. Wolfe,et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. , 2002, Journal of the American Society of Nephrology : JASN.
[24] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[25] J. Avorn,et al. Nephrologist care and mortality in patients with chronic renal insufficiency. , 2002, Archives of internal medicine.
[26] I. Khan,et al. Chronic renal failure: factors influencing nephrology referral. , 1994, QJM : monthly journal of the Association of Physicians.
[27] A. Kausz,et al. Opportunities to improve the care of patients with kidney transplant failure. , 2002, Kidney international.
[28] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .
[29] P. Roderick,et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] K Doqi,et al. clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .
[31] Ping Wang,et al. The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases , 1996, Annals of Internal Medicine.
[32] C. L. Plante. 1971 Medicare amendment: reflections on the passage of the end-stage renal disease Medicare program. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] J. Griffith,et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. , 2002, Journal of the American College of Cardiology.
[34] M. Fan,et al. The long-term effects of recombinant human erythropoietin on the cardiovascular system. , 1992, Clinical nephrology.
[35] Ruth E. Brown,et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] L. Huiart,et al. Timing of nephrology referral: influence on mortality and morbidity. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] M. Pfeffer,et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] R. Foley,et al. Anemia as a Risk Factor for Cardiac Disease in Dialysis Patients , 1999 .
[39] A. Levey. Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] K. Iseki,et al. Serum albumin is a strong predictor of death in chronic dialysis patients. , 1993, Kidney international.
[41] C. Schmid,et al. Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease , 2001, Annals of Internal Medicine.
[42] J. Kopple,et al. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[43] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[44] B. Kasiske,et al. Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.
[45] J. Domico,et al. Early referral and its impact on emergent first dialyses, health care costs, and outcome. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] A. Collins,et al. Hematocrit levels and hospitalization risks in hemodialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.
[47] David C. Murray,et al. Outcome and risk factors of ischemic heart disease in chronic uremia. , 1996, Kidney international.
[48] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[49] J. Singer,et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[50] P. Ratcliffe,et al. Late referral for maintenance dialysis. , 1984, British medical journal.
[51] G. Shearer,et al. Mechanisms of hypoalbuminemia in hemodialysis patients. , 1995, Kidney international.
[52] E G Lowrie,et al. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[53] A. Collins,et al. Trends in anemia at initiation of dialysis in the United States. , 2001, Kidney international.
[54] David C. Murray,et al. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[55] R. Foley,et al. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease and cardiac failure. Semin Dial 2003 , 2022 .
[56] T. Feest,et al. Management of anaemia in United Kingdom renal units: a report from the UK Renal Registry. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[57] A. Collins,et al. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] B. Ewigman,et al. The timing of referral of patients with end-stage renal disease , 1989 .